Evidence map›Paper›PMID 42388306›Full record

ArticleFrontiers in microbiology2026

Association between

Sureewan Bumrungthai, Sutida Pongpukdeesakul, Tipaya Ekalaksananan, Sureewan Duangjit, Chamsai Pientong, Nuchsupha Sunthamala

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sureewan BumrungthaiDivision of Biopharmacy, Faculty of Pharmaceutical Sciences, Ubon Ratchathani University, Ubon Ratchathani, Thailand.
Sutida PongpukdeesakulDivision of Microbiology and Parasitology, School of Medical Sciences, University of Phayao, Phayao, Thailand.
Tipaya EkalaksanananDepartment of Microbiology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Sureewan DuangjitDivision of Pharmaceutical Chemistry and Technology, Faculty of Pharmaceutical Sciences, Ubon Ratchathani University, Ubon Ratchathani, Thailand.
Chamsai PientongDepartment of Microbiology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Nuchsupha SunthamalaDepartment of Biology, Faculty of Science, Mahasarakham University, Mahasarakham, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Human herpesvirus 6 (HHV-6) establishes lifelong latency after primary infection and may reactivate under conditions of immune modulation. Tumor necrosis factor alpha (TNF- Methods: We conducted a community-based cross-sectional study of 852 participants aged 3-90 years in Phayao Province, Thailand. HHV-6 DNA was detected by nested PCR and quantitative PCR. Genotyping of Results: HHV-6 DNA was detected in 12.8% of participants and increased with age (adjusted OR per 10-year increase 1.55, 95% CI 1.35-1.78; Conclusion: In this Thai community cohort, the

Indexed as

cytokine gene polymorphismhuman herpesvirus 6 (HHV-6)molecular epidemiologyTNF polymorphismsviral latency and reactivation

Identifiers

PMID42388306
PMCPMC13318981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.